References
- Ko JM, Gottlieb AB, Kerbleski JF. Induction and exacerbation of psoriasis with TNF-blockade therapy: A review and analysis of 127 cases. J Dermatol Treat. 2009;20:100–108.
- Hassan AS, Dagmar S, Hans-Uwe S, Braathen LR, Yawalkar N. Efalizumab-associated papular psoriasis. Arch Dermatol. 2007;143:900–906.
- Nestle FO, Gilliet M. Defining upstream elements of psoriasis pathogenesis: An emerging role for interferon α. J Invest Dermatol. 2005;125(5):xiv–xv.
- Chan JR, Blumenshein W, Murphy E, Diveu C, Wiekowski M, Abbondanzo S, IL-23 stimulates epidermal hyperplasia via TNF and IL-20R2-dependent mechanisms with implications for psoriasis pathogenesis. J Exp Med. 2006;203:2577–2587.
- Gilliet M, Conrad C, Geiges M, Cozzio A, Thurlimann W, Burg G, Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol. 2004;140:1490–1495.
- Ladoyanni E, Nambi R. Psoriasis exacerbated by interferon-alpha in a patient with chronic myeloid leukemia. J Drugs Dermatol. 2005;4:221–222.
- Goiriz R, Dauden E, Perez-Gala S, Guhl G, Garcia-Diez A. Flare and change of psoriasis morphology during the course of treatment with tumor necrosis factor blockers. Clin Exp Dermatol. 2006;32:176–179.
- Iizuka H, Takahashi H, Ishida-Yamamoto A. Pathophysiology of generalized pustular psoriasis. Arch Dermatol Res. 2003;295:S55–S59.